Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03797482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary completion pushed from Sep 30, 2025 to Dec 30, 2026Enrollment closed, study ongoing · Completion pushed from Nov 30, 2025 to Dec 30, 2026 · Eligibility criteria expanded, about 6 words · 4 moreShow 7 more changesShow less
Enrollment closed, study ongoing
Completion pushed from Nov 30, 2025 to Dec 30, 2026
Eligibility criteria expanded, about 6 words
Secondary endpoints: details revised at 1 of 1 entry
Site details revised
Publications: details revised at 3 of 4 entries
Study description expanded, about 3 words
MinorPrimary completion date: Jul 30, 2025 to Sep 30, 2025v8
NotablePrimary completion date: Jul 30, 2024 to Jul 30, 2025v7
NotablePrimary completion date: Jul 30, 2022 to Jul 30, 2024Completion date: Nov 30, 2022 to Nov 30, 2025v6Show 1 more changeShow less
Completion date: Nov 30, 2022 to Nov 30, 2025
NotablePrimary completion date: Nov 30, 2021 to Jul 30, 2022v5
Show 3 earlier versionsHide 3 earlier versions
NotablePrimary completion date: Nov 30, 2020 to Nov 30, 2021v4
NotablePrimary completion date: Nov 30, 2019 to Nov 30, 2020v3
NotablePhase: Not applicable to Not specifiedv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during the surgery after partial devascularisation (sample B) and stored for future genomic and proteonomic evaluations.